To study the role of TRPM2 in neuroblastoma tumor growth and chemotherapy sensitivity, SH-SY5Y neuroblastoma cells in which TRPM2 was depleted with CRISPR technology (5) or cells that stably expressed the dominant negative splice variant TRPM2-S (9) were utilized. The gene discussed is TRPM2; the disease is neoplasm.